Abstract
Preterm newborns have low serum thyroxine (T4) levels compared with late-gestational fetuses. Low thyroid hormone levels are associated with increased severity of neonatal illness and neurodevelopmental dysfunction. We assessed the endocrine and clinical effects of increasing serum T4 levels in preterm newborns with a gestational age <31 wk. Forty newborns were randomized in a double blind protocol: 20 infants received a daily dose of 20 μg/kg l-T4 for 2 wk, whereas 20 control infants received saline. Serum concentrations of T4, triiodothyronine (T3), reverse T3 (rT3), thyroglobulin (TG), and TSH were measured weekly as well as serum levels of GH, prolactin, and IGF-I. After 2 wk, a TSH-releasing hormone (TRH) test was performed. Neonatal illness and outcome was evaluated by noting heart rate, oxygen requirement, duration of ventilation, development of chronic lung disease, oral fluid intake, and weight gain; a Bayley score was done at the corrected age of 7 mo. l-T4 administration induced a marked increase in serum T4 without apparent change in T3 levels, whereas the postnatal decline in serum rT3 was more gradual. l-T4 treatment was associated with a decrease in serum TG and TSH levels. TRH injection induced a definite rise in serum TSH and T3 in controls, but not in L-T4 treated newborns. Neither l-T4 treatment, nor TRH administration appeared to alter circulating levels of prolactin, GH, or IGF-I. In contrast to the pronounced endocrine effects, no clinical effects of l-T4 administration were detected.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- T4:
-
thyroxine
- L-T4:
-
L-thyroxine
- T3:
-
triiodothyronine
- rT3:
-
reverse triiodothyronine
- TG:
-
thyroglobulin
- TBG:
-
thyroid-binding globulin
- TRH:
-
TSH-releasing hormone
- PRL:
-
prolactin
References
Fisher DA, Klein AH 1981 Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304: 702–712.
Fisher DA, Polk DH 1989 Development of the thyroid. Baillieres Clin Endocrinol Metabol 3: 627–657.
Burrow GN, Fisher DA, Larsen PR 1994 Maternal and fetal thyroid function. N Engl J Med 331: 1072–1078.
Ballabio M, Nicolini U, Jowett T, Ruiz de Elvira MC, Ekins RP, Rodeck CH 1989 Maturation of thyroid function in normal foetuses. Clin Endocrinol 31: 565–571.
Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM 1991 Maturation of the secretion of thyroid hormone and thyroid stimulating hormone in the fetus. N Engl J Med 324: 532–536.
Birk E, Tyndall R, Erickson LC, Rudolph AM, Roberts JM 1992 Effects of thyroid hormone on myocardial beta-receptor responsiveness and function during late gestation. Pediatr Res 31: 468–473.
Lebenthal E, Lee PC 1983 Interaction of determinants in the ontogeny of the gastrointestinal tract: a unified concept. Pediatr Res 17: 19–24.
de Zegher F, Pernasetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial J 1995 The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 80: 3127–3130.
Hetzel BS, Dunn JT 1989 The iodine deficiency disorders: their nature and prevention. Annu Rev Nutr 9: 21–38.
Calvo RM, Obregon MJ, Ruiz de Ona C, Escobar del Rey F, Morreale de Escobar G 1990 Congenital hypothyroidism as studied in rats: crucial role of maternal thyroxine but not of 3,5,3′-triiodothyronine in the protection of the fetal brain. J Clin Invest 86: 889–899.
Eggermont E, Vanderschueren-Lodeweyckx M, De Nayer Ph, Smeets E, Vanacker G, Cornette C, Jaeken J, Devlieger H, Eeckels R, Beckers C 1984 The thyroid-system function in preterm infants of postmenstrual ages 31 wk or less: evidence for a “transient lazy thyroid system.”. Helv Paediatr Acta 39: 209–222.
Mercado M, Yu VYH, Francis I, Szymonowicz W, Gold H 1988 Thyroid function in very preterm infants. Early Hum Dev 16: 131–141.
Hadeed AJ, Asay LD, Klein AH, Fisher DA 1981 Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome. Pediatrics 68: 494–498.
Chowdhry P, Scanlon JW, Auerbach R, Abbassi V 1984 Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 73: 301–304.
Amato M, Pasquier S, Carasso A, Von Muralt G 1988 Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants. Hormone Res 29: 27–30.
Karna P 1991 Developmental follow-up of very low birthweight premature infants with low free thyroxine. Am J Perinatol 8: 288–91.
Schönberger W, Grimm W, Emmrich P, Gempp W 1981 Reduction of mortality rate in premature infants by substitution of thyroid hormones. Eur J Pediatr 135: 245–253.
de Vries LS, Heckmatt JZ, Burrin JM, Dubowitz LMS, Dubowitz V 1986 Low serum thyroxine concentrations and neural maturation in preterm infants. Arch Dis Child 862: 866
Kohelet D, Arbel E, Goldberg M, Arlazzaroff A 1992 Transient neonatal hypothyroxinemia and the auditory brainstem evoked response. Pediatr Res 32: 530–531.
Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL 1992 Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Child 67: 944–947.
Marsh TD, Freeman D, McKeown RE, Bowyer FP 1993 Increased mortality in neonates with low thyroxine values. J Perinatol 3: 201–204.
Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP 1996 The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very pretrem and/or very low birth weight infants. Pediatr Res 39: 142–145.
Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M 1996 The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 334: 821–827.
de Zegher F, Devlieger H, Veldhuis JD 1992 Pulsatile and sexually dimorphic secretion of luteinizing hormone in the human infant on the day of birth. Pediatr Res 32: 605–607.
Northway WH, Rosan RC, Porter DY 1967 Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med 267: 357–374.
Bayley N 1969 Manual for the Bayley Scales of Infant Development. The Psychological Corporation, New York
Van Wassenaer AG, Kok JH, Endert E, Vulsma T, de Vijlder JJM 1993 Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinol 129: 139–146.
de Zegher F, Van den Berghe G, Devlieger H, Eggermont E, Veldhuis JD 1993 Dopamine inhibits neonatal growth hormone and prolactin hypersecretion. Pediatr Res 34: 642–645.
de Zegher F, Van den Berghe G, Dumoulin M, Gewillig M, Daenen W, Devlieger H 1995 Dopamine suppresses thyroid-stimulating hormone secretion in neonatal hypothyroidism. Acta Pediatr 84: 213–214.
Van den Berghe G, de Zegher F, Lauwers P 1994 Dopamine suppresses pituitary function in infants and children. Crit Care Med 22: 1747–1753.
Acknowledgements
The authors thank the Medical and Nursing Staff of the Neonatal Intensive Care Unit for their cooperation in this study.
Author information
Authors and Affiliations
Additional information
Supported by the Belgian Study Group for Pediatric Endocrinology, the University of Leuven (OT 95/24), and the Belgian Fund for Scientific Research(G-0162-96).
Rights and permissions
About this article
Cite this article
Vanhole, C., Aerssens, P., Naulaers, G. et al. L-Thyroxine Treatment of Preterm Newborns: Clinical and Endocrine Effects. Pediatr Res 42, 87–92 (1997). https://doi.org/10.1203/00006450-199707000-00014
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199707000-00014
This article is cited by
-
Clinical indicators that influence a clinician’s decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia
Italian Journal of Pediatrics (2023)
-
Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity
Scientific Reports (2022)
-
Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months
European Journal of Pediatrics (2022)
-
Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants
Scientific Reports (2019)
-
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial
Trials (2013)
